Exponent Elevates John Pye to President and Eric Anderson to CFO Reporting to Catherine Corrigan, CEO; Rich Schlenker to Remain as Executive VP and to Stand for Election to ...

(Nasdaq:EXPO), a leading engineering and scientific consulting firm, today announced its appointment of John Pye to President and Eric Anderson to Chief Financial Officer, both effective May 1, 2026 ...
pharmaphorum

AI biotechs Exscientia and Recursion agree $688m merger

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
EDN

A convenient desktop-accessible calculator of E-series component values

It’s convenient at times to have a desktop calculator that accepts a computed value x and returns the standard, commercially available value closest to it for a specified E series. Here, “closest” ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...